Endothelin-1-induced mitogenic responses of Chinese hamster ovary cells expressing human endothelinA: The role of a Wortmannin-sensitive signaling pathway

Molecular Pharmacology

Volumn 49, Issue 3, 1996, Pages 447-457

  Sugawara, Fumiaki ^a   Ninomiya, Haruaki ^a   Okamoto, Yasuo ^a   Miwa, Soichi ^a   Mazda, Osam ^a,b   Katsura, Yoshimoto ^a   Masaki, Tomoh ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1; WORTMANNIN;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CANCER; CARCINOGENESIS; CHO CELL; HYPERLIPOPROTEINEMIA; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; AMINO ACID SEQUENCE; ANDROSTADIENES; ANIMALS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL DIVISION; CHO CELLS; CRICETINAE; CYTOCHROME P-450 ENZYME SYSTEM; DRUG INTERACTIONS; ENDOTHELINS; ENZYME ACTIVATION; ESTRENES; GUINEA PIGS; HUMANS; MOLECULAR SEQUENCE DATA; PHOSPHODIESTERASE INHIBITORS; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RAF; PYRROLIDINONES; RECEPTOR, ENDOTHELIN A; RECEPTORS, ENDOTHELIN; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; TETRADECANOYLPHORBOL ACETATE; TRANSFECTION;

EID: 0029921677     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Yanagisawa, M., H. Kurihara, S. Kimura, Y. Tomobe, M. Kobayashi, Y. Mitui, Y. Yazaki, K. Goto, and T. Masaki. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature (Lond.) 332:411-415 (1988).
2. Inoue, A., M. Yanagisawa, S. Kimura, Y. Kasuya, T. Miyauchi, K. Goto, and T. Masaki. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc. Natl. Acad. Sci. USA 86:2863-2867 (1989).
3. Masaki, T., M. Yanagisawa, and K. Goto. Physiology and pharmacology of endothelins. Med. Res. Rev. 12:391-421 (1992).
4. Rubanyi, G. M., and M. A. Polokoff. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol. Rev. 46:325-415 (1994).
5. Arendt, R. M., U. W. Lampen, L. Heucke, K. Suhler, M. Ritter, and W. O. Richter. Ir-ET circulates in human plasma: elevated concentrations in patients with hyperlipoproteinemia. Am. J. Hypertens. 3:336-342 (1989).
6. Lerman, A., B. S. Edwards, J. W. Hallett, D. M. Heublein, S. M. Soderg, and J. C. Burnett. Circulatuig and tissue ir-ET in advanced atherosclerosis. N. Engl. J. Med. 325:997-1001 (1991).
7. Shichin, M., Y. Hirata, T. Nakajima, K. Ando, T. Imai, M. Yanagisawa, T. Masaki, and F. Marumo. Endothelin-1 is an autocrine/paracrine growth factor for human cancer cell lines. J. Clin. Invest. 87:1867-1871 (1991).
8. Kurihara, Y., H. Kurihara, H. Suzuki, T. Kodama, K. Maemura, R. Nagai, H. Oda, T. Kuwai, W.-H. Cao, N. Kamada, K. Jishage, Y. Ouchi, S. Azuma, Y. Toyoda, T. Ishikawa, M. Kumada, and Y. Yazaki. Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1. Nature (Lond.) 368:703-710 (1994).
9. Baynash, A. M., K. Hosoda, A. Giaid, J. A. Richardson, N. Emoto, R. E. Hammer, and M. Yanagisawa. Interaction of endothelin-3 with endothelin-B receptor is essential for development of epidermal melanocytes and enteric neurons. Cell 79:1277-1285 (1994).
10. Arai, H., S. Hori, S. Aramori, H. Ohkubo, and S. Nakanishi. Cloning and expression of a cDNA encoding an endothelin receptor. Nature (Lond.) 348:730-732 (1990).
11. Sakurai, T., M Yanagisawa, Y. Takawa, H. Miyazaki, S. Kimura, K. Goto, and T. Masaki. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor Nature (Lond.) 348:732-735 (1990).
12. Simonson, M. S., and W. H. Herman. Protein kinase C and protein tyrosine kinase activity contribute to mitogenic signaling by endothelin-1. J. Biol. Chem. 268:9347-9357 (1993).
13. A receptor antagonist BQ-123 antagonizes ET-1 mediated mitogenesis. Eur. J. Pharmacol. 225:347-350 (1992).
14. A antagonist (BQ123) inhibits ET-1 induced PI breakdown and DNA synthesis in rat vascular SMC. FEBS Lett. 302:243-246 (1992).
15. Roubert, P., V. Gillard, P. Plas, P. E. Chabrier, and P. Braquet. Binding characteristics of endothelin isoforms (ET-1, ET-2, and ET-3) in vascular smooth muscle cells. J. Cardiovasc. Pharmacol. 17:3104-8108 (1991).
16. Alberts, G. F., K. A. Peifley, A. Johns, J. F. Kleha, and J. A. Winkles. Constitutive endothelin-1 overexpression promotes smooth muscle cell proliferation via an external autocrine loop. J. Biol. Chem. 269:10112-10118 (1994).
17. B-selective agonists. J. Biol Chem. 268:8547-3553 (1993).
18. A/B chimeras. J. Biol. Chem. 270:10072-10078 (1995).
19. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260:3440-3450 (1985).
20. Traynor-Kaplan, A. E., A. L. Harris, B. L. Thompson, P. Taylor, G. M Omann, and L. A. Sklar. Transient increase in phosphatidylinositol 3,4-bisphosphate and phosphatidylinositol trisphosphate during activation of human neutrophils. J Biol. Chem. 264:15668-15673 (1989).
21. Fujitara, Y., H. Ninomiya, T. Okada, Y. Urade, and T. Masaki Suppression of endothelin-1-induced mitogenic responses of human aortic smooth muscle cells by interleukin-1β. J. Clin. Invest. 95:2474-2482 (1995).
22. Samuels, M. L., M. J. Weber, J. M. Bishop, and M. MacMahon. Conditional transformation of cells and rapid activation of the mitogen-activated protein kinase cascade by estradiol-dependent human raf-1 protein kinase. Mol. Cell. Biol. 13:6241-6252 (1993).
23. Cross, D. A., D. R. Alessi, J. R. Vandenheede, H. E. McDowell, H. S. Hundal, and P. Cohen. The inhibition of glycogen synthase kinase-3 by insulin or insulin-like growth factor 1 in the rat skeletal muscle cell line L6 is blocked by wortmannin, but not by rapamycin: evidence that wortmannin blocks activation of the mitogen-activated protein kinase pathway in L6 cells between ras and raf. Biochem. J. 303:21-26 (1994).
24. Takuwa, N., Y. Takuwa, M. Yanagisawa, K. Yamashita, and T. Masaki. A novel vasoactive peptide endothelin stimulates mitogenesis through inositol lipid turnover in Swiss 3T3 fibroblasts. J. Biol. Chem. 264:7856-7861 (1989).
25. Ferby, I. M., I. Waga, C. Sakanaka, K. Kume, and T. Shimizu. Wortmannin inhibits mitogen-activated protein kinase activation induced by platelet-activating factor in guinea pig neutrophils. J. Biol. Chem. 269:30485-30488 (1994).
26. Sakanaka, C., I. M. Ferby, I. Waga, H. Bito, and T. Shimizu. On the mechanism of cytosolic phospholipase A2 activation in CHO cells carrying somatostatin receptor: wortmannin-sensitive pathway to activate mitogen-activated protein kinase. Biochem. Biophys. Res. Commun. 30:18-23 (1994).
27. Kolch, W., G. Heidecker, G Kochs, R Hummel, H. Vahidi, H. Mischak, G. Finkenzeller, D. Marmé, and U. E. Rapp. Protein kinase Cα activates RAF-1 by direct phosphorylation. Nature (Lond.) 364:249-252 (1993).
28. Stephens, L., T. Jackson, and P. T. Hawkins. Synthesis of phosphatidylinositol 3,4,5-trisphosphate in permeabilized neutrophils regulated by receptors and G-proteins. J. Biol. Chem. 268:17162-17172 (1993).
29. Okada, T., L. Sakuma, Y. Fukui, O. Hazeki, and M. Ui. Blockage of chemotactic peptide-induced stimulation of neutrophils by wortmannin as a result of selective inhibition of phosphatidylinositol 3-kinase. J. Biol. Chem. 269:3563-3567 (1994).
30. Stephens, L., A. Smrcka, F. T. Cooke, T R. Jackson, P. C. Sternweis, and P. T. Hawkins. A novel phosphoinositide 3 kinase activity in myeloid-derived cells is activated by G protein beta gamma subunits. Cell 77:83-93 (1994).
31. Stoyanov, B., S Volinia, T. Hanck, I. Rubio, M. Loubtchenkov, D. Malek, S. Stoyanova, B. Vanhaesebroeck, R. Dhand, B. Nürnberg, P. Giershik, K. Seedorf, J. J. Hsuan, M. D. Waterfield, and R. Wetzker. Cloning and characterization of a G protein-activated human phosphoinositide-3 kinase. Science (Washington D. C.) 269:690-693 (1995).
32. Franke, T. F., S. I. Yang, T. O. Chan, K. Datta, A. Kazlauskas, D. K. Morrison, D. R. Kaplan, and P N. Tsichlis. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 81:727-736 (1995).
33. Boudewijn, M., T. Burgering, and P. J. Coffer. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature (Lond.) 376:599-602 (1995).
34. Singh, S. S., A. Chauhan, H. Brockerhoff, and V. P. Chauhan. Activation of protein kinase C by phosphatidylinositol 3,4,5-trisphosphate. Biochem. Biophys. Res. Commun. 195:104-112 (1993).
35. Nakanishi H., K. A. Brewer, and J H. Exton. Activation of the zeta isozyme of protein kinase C by phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem. 268:13-16 (1993).
36. Monfar, M., K. P. Lemon, T. C Grammer, L. Cheatham, J. Chung, C. J. Vlahos, and J. Blenis. Activation of pp70/85 S6 kinases in interleukin-2-responsive lymphoid cells is mediated by phosphatidylinositol 3-kinase and inhibited by cyclic AMP. Mol. Cell. Biol. 15:326-337 (1995).
37. Nobes, C. D., P Hawlans, L. Stephens, and A. Hall. Activation of the small GTP-binding proteins rho and rac by growth factor receptors. J. Cell Sci 108:225-33 (1995).
38. Kotani, K. K. Hara, K. Kotani, K. Yonezawa, and M. Kasuga. Phosphoinositide 3-kinase as an upstream regulator of the small GTP-binding protein Rac in the insulin signaling of membrane ruffling. Biochem. Biophys. Res Commun. 208:985-990 (1995).
39. Standaert, M. L, G. Bandyopadhyay, and R. V. Farese. Studies with wortmannin suggest a role for phosphatidylinositol 3-kinase in the activation of glycogen synthase and mitogen-activated protein kinase by insulin in rat adipocytes: comparison of insulin and protein kinase C modulators. Biochem. Biophys. Res. Commun., 209:1082-1088 (1995).
40. Karnitz, L. M., L. A. Burns, S. L. Sutor, J. Blenis, and R. T. Abraham. Interleukin-2 triggers a novel phosphatidylinositol 3-kinase-dependent MEK activation pathway. Mol. Cell. Biol. 15:3049-3057 (1995).
41. Koide, M., Y. Kawahara, T. Tsuda, Y. Ishida, K. Shii, and M. Yokoyama. Endothelin-1 stimulates tyrosine phosphorylation and the activities of two mitogen-activated protein kinases in cultured smooth muscle cells. J. Hypertens. 10:1173-1182 (1992).
42. Weissberg, P. L., C. Witchell, A. P. Davenport, T R. Hesketh, and J. C. Metcalfe. The endothelin peptides ET-1, ET-2, ET-3 and sarafotoxin S6B are co-mitogenic with platelet-derived growth factor for vascular smooth muscle cells. Atherosclerosis 85:257-262 (1990).
43. Komuro, I., H. Kurihara, T. Sugiyama, F. Takuwa, and Y. Yazaki. Endothelin stimulates c-fos and c-myc expression and proliferation of vascular smooth muscle cells. FEBS Lett. 238:249-252 (1988).
44. Muldoon, L. L., D. Pribnow, K. D. Rodland, and B. E. Magun. Endothelin induces transcription of fos/jun family genes: a prominent role for calcium ion. Cell Regul. 1:379-390 (1990).
45. Kusuhara, M., K. Yamaguchi, M. Kuranami, A. Suzaki, S. Ishikawa, H. Moon, I. Adachi, S. Hori, and S. Handa. Stimulation of anchorage-independent cell growth by endothelin in NRK 49F cells. Cancer Res. 52:3011-3014 (1992).